

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vacuole organization (GO:0044088) | 8.97780171 |
| 2 | angiotensin maturation (GO:0002003) | 8.97526615 |
| 3 | negative regulation of organelle assembly (GO:1902116) | 8.53587507 |
| 4 | cytidine metabolic process (GO:0046087) | 8.36163134 |
| 5 | cytidine catabolic process (GO:0006216) | 8.36163134 |
| 6 | cytidine deamination (GO:0009972) | 8.36163134 |
| 7 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 8.16041127 |
| 8 | sulfate transmembrane transport (GO:1902358) | 7.62322105 |
| 9 | bile acid and bile salt transport (GO:0015721) | 7.35004412 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.32406347 |
| 11 | protein neddylation (GO:0045116) | 7.24337895 |
| 12 | negative regulation of T cell differentiation in thymus (GO:0033085) | 7.15735861 |
| 13 | negative regulation of keratinocyte proliferation (GO:0010839) | 6.98846329 |
| 14 | keratinocyte development (GO:0003334) | 6.96657390 |
| 15 | chondrocyte proliferation (GO:0035988) | 6.96166123 |
| 16 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 6.80394815 |
| 17 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 6.80394815 |
| 18 | intestinal absorption (GO:0050892) | 6.73641791 |
| 19 | regulation of vitamin metabolic process (GO:0030656) | 6.68314931 |
| 20 | NADH metabolic process (GO:0006734) | 6.55912769 |
| 21 | sulfate transport (GO:0008272) | 6.33526189 |
| 22 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.08634157 |
| 23 | alkaloid metabolic process (GO:0009820) | 5.98713908 |
| 24 | positive regulation of T cell differentiation in thymus (GO:0033089) | 5.88192438 |
| 25 | epoxygenase P450 pathway (GO:0019373) | 5.56133902 |
| 26 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.53524412 |
| 27 | somite development (GO:0061053) | 5.28986751 |
| 28 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 5.28831821 |
| 29 | endocrine process (GO:0050886) | 5.28007223 |
| 30 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.28007223 |
| 31 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.28007223 |
| 32 | regulation of cellular extravasation (GO:0002691) | 5.23331658 |
| 33 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 5.15426705 |
| 34 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 5.15426705 |
| 35 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 5.15426705 |
| 36 | positive regulation of respiratory burst (GO:0060267) | 5.14770078 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 5.12554367 |
| 38 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 5.05458959 |
| 39 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.01076939 |
| 40 | renal system process involved in regulation of blood volume (GO:0001977) | 4.97858065 |
| 41 | positive regulation of pseudopodium assembly (GO:0031274) | 4.91798972 |
| 42 | regulation of viral release from host cell (GO:1902186) | 4.88989814 |
| 43 | mitotic G2 DNA damage checkpoint (GO:0007095) | 4.88262899 |
| 44 | lipoprotein transport (GO:0042953) | 4.84635136 |
| 45 | negative regulation of receptor activity (GO:2000272) | 4.83722411 |
| 46 | regulation of cGMP biosynthetic process (GO:0030826) | 4.78606270 |
| 47 | fructose metabolic process (GO:0006000) | 4.77808570 |
| 48 | regulation of systemic arterial blood pressure (GO:0003073) | 4.77137715 |
| 49 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.60931477 |
| 50 | antibacterial humoral response (GO:0019731) | 4.52478681 |
| 51 | glucuronate metabolic process (GO:0019585) | 4.50576951 |
| 52 | uronic acid metabolic process (GO:0006063) | 4.50576951 |
| 53 | hormone catabolic process (GO:0042447) | 4.50129767 |
| 54 | regulation of keratinocyte proliferation (GO:0010837) | 4.50113556 |
| 55 | diacylglycerol metabolic process (GO:0046339) | 4.44895922 |
| 56 | antimicrobial humoral response (GO:0019730) | 4.41818889 |
| 57 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.41353369 |
| 58 | regulation of pseudopodium assembly (GO:0031272) | 4.41352929 |
| 59 | epithelial cell-cell adhesion (GO:0090136) | 4.40504576 |
| 60 | sulfur compound transport (GO:0072348) | 4.33811311 |
| 61 | establishment of skin barrier (GO:0061436) | 4.30228355 |
| 62 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.27297976 |
| 63 | drug metabolic process (GO:0017144) | 4.23283106 |
| 64 | regulation of bile acid biosynthetic process (GO:0070857) | 4.13308352 |
| 65 | glomerular filtration (GO:0003094) | 4.10994200 |
| 66 | negative regulation of response to nutrient levels (GO:0032108) | 4.01974203 |
| 67 | negative regulation of response to extracellular stimulus (GO:0032105) | 4.01974203 |
| 68 | neurotransmitter biosynthetic process (GO:0042136) | 3.96413124 |
| 69 | regulation of cGMP metabolic process (GO:0030823) | 3.96188902 |
| 70 | urea cycle (GO:0000050) | 3.95539732 |
| 71 | positive regulation of epidermis development (GO:0045684) | 3.94636117 |
| 72 | cGMP-mediated signaling (GO:0019934) | 3.93586095 |
| 73 | extracellular matrix assembly (GO:0085029) | 3.92876782 |
| 74 | regulation of water loss via skin (GO:0033561) | 3.91707739 |
| 75 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.90271619 |
| 76 | bone resorption (GO:0045453) | 3.89204204 |
| 77 | adhesion of symbiont to host cell (GO:0044650) | 3.88809544 |
| 78 | virion attachment to host cell (GO:0019062) | 3.88809544 |
| 79 | peptide catabolic process (GO:0043171) | 3.83770168 |
| 80 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.79454114 |
| 81 | ethanol oxidation (GO:0006069) | 3.77983515 |
| 82 | flavonoid metabolic process (GO:0009812) | 3.77041188 |
| 83 | regulation of respiratory burst (GO:0060263) | 3.76198511 |
| 84 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.75773036 |
| 85 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.75771469 |
| 86 | renal filtration (GO:0097205) | 3.75026267 |
| 87 | urea metabolic process (GO:0019627) | 3.74301158 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72322491 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.63310405 |
| 90 | mitotic G2/M transition checkpoint (GO:0044818) | 3.63301063 |
| 91 | peptide hormone processing (GO:0016486) | 3.63062767 |
| 92 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 3.59738416 |
| 93 | nucleoside bisphosphate metabolic process (GO:0033865) | 3.59738416 |
| 94 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 3.59738416 |
| 95 | nucleotide salvage (GO:0043173) | 3.57071627 |
| 96 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.57002368 |
| 97 | oligosaccharide biosynthetic process (GO:0009312) | 3.54359043 |
| 98 | glycosphingolipid catabolic process (GO:0046479) | 3.53792343 |
| 99 | positive regulation of protein export from nucleus (GO:0046827) | 3.53642493 |
| 100 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.52680291 |
| 101 | transcytosis (GO:0045056) | 3.52227394 |
| 102 | response to hepatocyte growth factor (GO:0035728) | 3.51423321 |
| 103 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.51423321 |
| 104 | ATP synthesis coupled proton transport (GO:0015986) | 3.51420512 |
| 105 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.51420512 |
| 106 | glycolipid catabolic process (GO:0019377) | 3.51142387 |
| 107 | actin filament depolymerization (GO:0030042) | 3.51009743 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50572066 |
| 109 | oxidative phosphorylation (GO:0006119) | 3.50269158 |
| 110 | digestion (GO:0007586) | 3.49962341 |
| 111 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.48997308 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 3.47053868 |
| 113 | digestive system process (GO:0022600) | 3.38368692 |
| 114 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37365083 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.36327028 |
| 116 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.32520918 |
| 117 | regulation of T cell differentiation in thymus (GO:0033081) | 3.31048237 |
| 118 | adhesion of symbiont to host (GO:0044406) | 3.29211438 |
| 119 | regulation of cholesterol homeostasis (GO:2000188) | 3.28186018 |
| 120 | glucocorticoid biosynthetic process (GO:0006704) | 3.27800052 |
| 121 | smooth muscle tissue development (GO:0048745) | 3.27338680 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 3.26938568 |
| 123 | regulation of triglyceride catabolic process (GO:0010896) | 3.26876710 |
| 124 | regulation of guanylate cyclase activity (GO:0031282) | 3.26594478 |
| 125 | plasma lipoprotein particle assembly (GO:0034377) | 3.24656962 |
| 126 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.22857126 |
| 127 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.22630537 |
| 128 | epithelial structure maintenance (GO:0010669) | 3.21053817 |
| 129 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.20161238 |
| 130 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.19043438 |
| 131 | regulation of developmental pigmentation (GO:0048070) | 3.18895058 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 3.17641933 |
| 133 | auditory receptor cell differentiation (GO:0042491) | 3.16322632 |
| 134 | positive regulation of chondrocyte differentiation (GO:0032332) | 3.15708294 |
| 135 | eosinophil chemotaxis (GO:0048245) | 3.13743541 |
| 136 | drug transmembrane transport (GO:0006855) | 3.13697785 |
| 137 | positive regulation of hair cycle (GO:0042635) | 3.13036644 |
| 138 | positive regulation of hair follicle development (GO:0051798) | 3.13036644 |
| 139 | cellular response to nitric oxide (GO:0071732) | 3.11911489 |
| 140 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.11056880 |
| 141 | nucleoside salvage (GO:0043174) | 3.09951161 |
| 142 | vitamin transport (GO:0051180) | 3.09233842 |
| 143 | GDP-mannose metabolic process (GO:0019673) | 3.08826312 |
| 144 | negative regulation of autophagy (GO:0010507) | 3.08032467 |
| 145 | pyrimidine nucleoside salvage (GO:0043097) | 3.07906277 |
| 146 | pyrimidine-containing compound salvage (GO:0008655) | 3.07906277 |
| 147 | O-glycan processing (GO:0016266) | 3.05610551 |
| 148 | negative regulation of defense response to virus (GO:0050687) | 3.05197397 |
| 149 | response to nitric oxide (GO:0071731) | 3.04147190 |
| 150 | protein-lipid complex assembly (GO:0065005) | 3.02440461 |
| 151 | arginine metabolic process (GO:0006525) | 3.01174166 |
| 152 | respiratory electron transport chain (GO:0022904) | 3.00911121 |
| 153 | drug catabolic process (GO:0042737) | 3.00191047 |
| 154 | vitamin A metabolic process (GO:0006776) | 2.98188777 |
| 155 | cGMP biosynthetic process (GO:0006182) | 2.97782165 |
| 156 | drug transport (GO:0015893) | 2.94017587 |
| 157 | sexual reproduction (GO:0019953) | 2.93106938 |
| 158 | electron transport chain (GO:0022900) | 2.92550308 |
| 159 | glycerol metabolic process (GO:0006071) | 2.91215874 |
| 160 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.90770540 |
| 161 | ethanol metabolic process (GO:0006067) | 2.90480861 |
| 162 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.89959868 |
| 163 | desmosome organization (GO:0002934) | 2.89198787 |
| 164 | neurotransmitter metabolic process (GO:0042133) | 2.87105666 |
| 165 | heterochromatin organization (GO:0070828) | 2.84190703 |
| 166 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.82385139 |
| 167 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.80419863 |
| 168 | cellular ketone body metabolic process (GO:0046950) | 2.78874669 |
| 169 | vitamin transmembrane transport (GO:0035461) | 2.78427488 |
| 170 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.76238914 |
| 171 | release of cytochrome c from mitochondria (GO:0001836) | 2.75606709 |
| 172 | sulfation (GO:0051923) | 2.73588682 |
| 173 | cellular response to cAMP (GO:0071320) | 2.73290547 |
| 174 | regulation of cholesterol metabolic process (GO:0090181) | 2.73044212 |
| 175 | embryonic digestive tract morphogenesis (GO:0048557) | 2.72796232 |
| 176 | cellular glucuronidation (GO:0052695) | 2.72002807 |
| 177 | intestinal epithelial cell development (GO:0060576) | 2.69969798 |
| 178 | phospholipid homeostasis (GO:0055091) | 2.69946981 |
| 179 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69719263 |
| 180 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.69451281 |
| 181 | mitochondrion localization (GO:0051646) | 2.63311223 |
| 182 | negative regulation of chemokine production (GO:0032682) | 2.60989997 |
| 183 | regulation of autophagic vacuole assembly (GO:2000785) | 11.0280002 |
| 184 | negative regulation of macroautophagy (GO:0016242) | 10.7604241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.31619860 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.25797634 |
| 3 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.18388867 |
| 4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.03988729 |
| 5 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.89334453 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.88002552 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.86049785 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.77275507 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61130047 |
| 10 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.45034471 |
| 11 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.38546618 |
| 12 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.34454363 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21926602 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.19038714 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.18504555 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.17987633 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.12040932 |
| 18 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.96607474 |
| 19 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.94309565 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.93706842 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83079006 |
| 22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.78485523 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.74987604 |
| 24 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.73517813 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70426091 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65469081 |
| 27 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.60696868 |
| 28 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60372983 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.58889039 |
| 30 | RXR_22108803_ChIP-Seq_LS180_Human | 1.57905640 |
| 31 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.57722343 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56973823 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.51873105 |
| 34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.51294694 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50845993 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.50248375 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.50224817 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49803498 |
| 39 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.48912555 |
| 40 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.43292648 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43040147 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.42579094 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.41097492 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.40186814 |
| 45 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.38702257 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37135100 |
| 47 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35511224 |
| 48 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.33676853 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30952871 |
| 50 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.27362402 |
| 51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.27244859 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26258400 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25474474 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23872835 |
| 55 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.23848386 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22923906 |
| 57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.22325481 |
| 58 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.22055570 |
| 59 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.21956713 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21905230 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20386695 |
| 62 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19864648 |
| 63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.19560027 |
| 64 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.19096279 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18588634 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17108796 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17056560 |
| 68 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16828619 |
| 69 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16007633 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15778210 |
| 71 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.14703854 |
| 72 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.14272830 |
| 73 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14034047 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12929346 |
| 75 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.11772080 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10444792 |
| 77 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.09694739 |
| 78 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09479583 |
| 79 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09356185 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09174380 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07617339 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.07002291 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06848760 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06446267 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.06323803 |
| 86 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06252477 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.05209516 |
| 88 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.04466704 |
| 89 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.02203602 |
| 90 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02175347 |
| 91 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01858319 |
| 92 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01110522 |
| 93 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00522823 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00339976 |
| 95 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00173256 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99118020 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98872824 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98724560 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98354583 |
| 100 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97493707 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.97318356 |
| 102 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96761351 |
| 103 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.96489527 |
| 104 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96326219 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95580535 |
| 106 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95466472 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94529647 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94380796 |
| 109 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94132242 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93600119 |
| 111 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93417450 |
| 112 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93362307 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92818960 |
| 114 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92126598 |
| 115 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92126598 |
| 116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91919892 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90643683 |
| 118 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90607502 |
| 119 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.90004558 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89834832 |
| 121 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89083403 |
| 122 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89039390 |
| 123 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88420223 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88369237 |
| 125 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86916952 |
| 126 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86657919 |
| 127 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.85600917 |
| 128 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85479679 |
| 129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84895271 |
| 130 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.84462548 |
| 131 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84450543 |
| 132 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83883060 |
| 133 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.83713032 |
| 134 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83511464 |
| 135 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.83265133 |
| 136 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.83211310 |
| 137 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.83059029 |
| 138 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82718991 |
| 139 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81598347 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81381306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 9.93172467 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 9.22754488 |
| 3 | MP0003315_abnormal_perineum_morphology | 4.93174976 |
| 4 | MP0009379_abnormal_foot_pigmentation | 4.01395401 |
| 5 | MP0002822_catalepsy | 3.94764394 |
| 6 | MP0002234_abnormal_pharynx_morphology | 3.93826183 |
| 7 | MP0000462_abnormal_digestive_system | 3.70947966 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.47493531 |
| 9 | MP0009053_abnormal_anal_canal | 3.46927081 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.05367122 |
| 11 | MP0004147_increased_porphyrin_level | 2.94752331 |
| 12 | MP0009840_abnormal_foam_cell | 2.74621355 |
| 13 | MP0003878_abnormal_ear_physiology | 2.69622066 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 2.69622066 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.20259576 |
| 16 | MP0003866_abnormal_defecation | 2.17851277 |
| 17 | MP0005409_darkened_coat_color | 2.14638296 |
| 18 | MP0005360_urolithiasis | 2.11970716 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.06790698 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.97681494 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.94850006 |
| 22 | MP0005381_digestive/alimentary_phenotyp | 1.86273728 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.65746620 |
| 24 | MP0000477_abnormal_intestine_morphology | 1.65518090 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.57253119 |
| 26 | MP0003868_abnormal_feces_composition | 1.53304572 |
| 27 | MP0005332_abnormal_amino_acid | 1.51275419 |
| 28 | MP0001663_abnormal_digestive_system | 1.49164631 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.49153869 |
| 30 | MP0003252_abnormal_bile_duct | 1.47303630 |
| 31 | MP0005451_abnormal_body_composition | 1.46200553 |
| 32 | MP0001188_hyperpigmentation | 1.43141864 |
| 33 | MP0002796_impaired_skin_barrier | 1.39869939 |
| 34 | MP0003385_abnormal_body_wall | 1.38575752 |
| 35 | MP0005670_abnormal_white_adipose | 1.38525668 |
| 36 | MP0002876_abnormal_thyroid_physiology | 1.34132162 |
| 37 | MP0001873_stomach_inflammation | 1.33377645 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.31359818 |
| 39 | MP0004782_abnormal_surfactant_physiolog | 1.31007432 |
| 40 | MP0001765_abnormal_ion_homeostasis | 1.29525932 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.24826294 |
| 42 | MP0002098_abnormal_vibrissa_morphology | 1.23596125 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.23298505 |
| 44 | MP0005365_abnormal_bile_salt | 1.20932667 |
| 45 | MP0000613_abnormal_salivary_gland | 1.17312324 |
| 46 | MP0001501_abnormal_sleep_pattern | 1.16991002 |
| 47 | MP0003724_increased_susceptibility_to | 1.16709009 |
| 48 | MP0004947_skin_inflammation | 1.16659955 |
| 49 | MP0001764_abnormal_homeostasis | 1.15427197 |
| 50 | MP0000490_abnormal_crypts_of | 1.13686944 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.13217017 |
| 52 | MP0001756_abnormal_urination | 1.12210683 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.09854593 |
| 54 | MP0001664_abnormal_digestion | 1.07787733 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.07481062 |
| 56 | MP0003045_fibrosis | 1.07052992 |
| 57 | MP0002282_abnormal_trachea_morphology | 1.06881573 |
| 58 | MP0000762_abnormal_tongue_morphology | 1.04545143 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.03731899 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.03192436 |
| 61 | MP0000230_abnormal_systemic_arterial | 1.00499142 |
| 62 | MP0009785_altered_susceptibility_to | 1.00286451 |
| 63 | MP0003937_abnormal_limbs/digits/tail_de | 0.97745637 |
| 64 | MP0001845_abnormal_inflammatory_respons | 0.95977130 |
| 65 | MP0002166_altered_tumor_susceptibility | 0.95763103 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 0.95469172 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.93801860 |
| 68 | MP0000538_abnormal_urinary_bladder | 0.93570860 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 0.93327132 |
| 70 | MP0000609_abnormal_liver_physiology | 0.91436008 |
| 71 | MP0004043_abnormal_pH_regulation | 0.90942632 |
| 72 | MP0002971_abnormal_brown_adipose | 0.88765207 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.86281241 |
| 74 | MP0002932_abnormal_joint_morphology | 0.86157179 |
| 75 | MP0005025_abnormal_response_to | 0.84466347 |
| 76 | MP0003436_decreased_susceptibility_to | 0.83270579 |
| 77 | MP0004270_analgesia | 0.80532241 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.80386223 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.78938504 |
| 80 | MP0000163_abnormal_cartilage_morphology | 0.78802278 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.78176853 |
| 82 | MP0006082_CNS_inflammation | 0.75724227 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.75215929 |
| 84 | MP0010329_abnormal_lipoprotein_level | 0.74917341 |
| 85 | MP0005535_abnormal_body_temperature | 0.74241482 |
| 86 | MP0009115_abnormal_fat_cell | 0.73998439 |
| 87 | MP0005387_immune_system_phenotype | 0.73939368 |
| 88 | MP0001790_abnormal_immune_system | 0.73939368 |
| 89 | MP0004272_abnormal_basement_membrane | 0.72168264 |
| 90 | MP0005310_abnormal_salivary_gland | 0.68507615 |
| 91 | MP0002115_abnormal_skeleton_extremities | 0.68346454 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 0.68282489 |
| 93 | MP0002006_tumorigenesis | 0.67037736 |
| 94 | MP0008469_abnormal_protein_level | 0.65396485 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.64683191 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.64602175 |
| 97 | MP0004134_abnormal_chest_morphology | 0.63052939 |
| 98 | MP0003718_maternal_effect | 0.62648872 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.62366276 |
| 100 | MP0005165_increased_susceptibility_to | 0.62197332 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.62100162 |
| 102 | MP0002009_preneoplasia | 0.62031329 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.60716864 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.60552637 |
| 105 | MP0000249_abnormal_blood_vessel | 0.59957451 |
| 106 | MP0002132_abnormal_respiratory_system | 0.59946847 |
| 107 | MP0003879_abnormal_hair_cell | 0.59534246 |
| 108 | MP0002233_abnormal_nose_morphology | 0.59257387 |
| 109 | MP0003329_amyloid_beta_deposits | 0.59193900 |
| 110 | MP0004858_abnormal_nervous_system | 0.58933012 |
| 111 | MP0000377_abnormal_hair_follicle | 0.56478494 |
| 112 | MP0000566_synostosis | 0.55702017 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.55610734 |
| 114 | MP0008569_lethality_at_weaning | 0.54651222 |
| 115 | MP0001800_abnormal_humoral_immune | 0.54358084 |
| 116 | MP0000537_abnormal_urethra_morphology | 0.52786991 |
| 117 | MP0001849_ear_inflammation | 0.52461364 |
| 118 | MP0000604_amyloidosis | 0.52259428 |
| 119 | MP0000470_abnormal_stomach_morphology | 0.52101603 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.51941832 |
| 121 | MP0009250_abnormal_appendicular_skeleto | 0.50345750 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.50110597 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.49901658 |
| 124 | MP0005501_abnormal_skin_physiology | 0.49901225 |
| 125 | MP0001216_abnormal_epidermal_layer | 0.48139517 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.47979215 |
| 127 | MP0009672_abnormal_birth_weight | 0.46767683 |
| 128 | MP0008872_abnormal_physiological_respon | 0.44585647 |
| 129 | MP0003755_abnormal_palate_morphology | 0.43657676 |
| 130 | MP0005166_decreased_susceptibility_to | 0.43312235 |
| 131 | MP0000049_abnormal_middle_ear | 0.41369567 |
| 132 | MP0001340_abnormal_eyelid_morphology | 0.40443601 |
| 133 | MP0000367_abnormal_coat/_hair | 0.38537872 |
| 134 | MP0003300_gastrointestinal_ulcer | 0.37933036 |
| 135 | MP0003941_abnormal_skin_development | 0.37409789 |
| 136 | MP0008004_abnormal_stomach_pH | 0.34733971 |
| 137 | MP0002113_abnormal_skeleton_development | 0.33501355 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.32989042 |
| 139 | MP0003795_abnormal_bone_structure | 0.31632454 |
| 140 | MP0000467_abnormal_esophagus_morphology | 0.31100899 |
| 141 | MP0002148_abnormal_hypersensitivity_rea | 0.29771765 |
| 142 | MP0003303_peritoneal_inflammation | 0.29135986 |
| 143 | MP0005448_abnormal_energy_balance | 0.28678074 |
| 144 | MP0001485_abnormal_pinna_reflex | 0.28406881 |
| 145 | MP0002111_abnormal_tail_morphology | 0.27392998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.57368410 |
| 2 | Posterior subcapsular cataract (HP:0007787) | 7.43649864 |
| 3 | Flat acetabular roof (HP:0003180) | 6.74480523 |
| 4 | Neonatal short-limb short stature (HP:0008921) | 6.49195795 |
| 5 | Malnutrition (HP:0004395) | 6.44953481 |
| 6 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 6.26273789 |
| 7 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 6.15888982 |
| 8 | Cupped ribs (HP:0000887) | 6.01497848 |
| 9 | Flat capital femoral epiphysis (HP:0003370) | 6.01068720 |
| 10 | Hydroxyprolinuria (HP:0003080) | 5.85717459 |
| 11 | Abnormality of proline metabolism (HP:0010907) | 5.85717459 |
| 12 | Breech presentation (HP:0001623) | 5.78908746 |
| 13 | Metabolic alkalosis (HP:0200114) | 5.55362680 |
| 14 | Decreased circulating renin level (HP:0003351) | 5.43599225 |
| 15 | Abnormality of the 1st metacarpal (HP:0010009) | 5.10162372 |
| 16 | Irregular epiphyses (HP:0010582) | 5.09414062 |
| 17 | Ileus (HP:0002595) | 4.82169290 |
| 18 | Chronic diarrhea (HP:0002028) | 4.81152988 |
| 19 | Abnormality of renin-angiotensin system (HP:0000847) | 4.71389778 |
| 20 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 4.71094470 |
| 21 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.59281331 |
| 22 | Abnormality of carpal bone ossification (HP:0006257) | 4.59060893 |
| 23 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 4.57862003 |
| 24 | Flattened epiphyses (HP:0003071) | 4.55648997 |
| 25 | Spinal cord compression (HP:0002176) | 4.42532422 |
| 26 | Abnormality of vitamin B metabolism (HP:0004340) | 4.27744046 |
| 27 | Subcapsular cataract (HP:0000523) | 4.25863608 |
| 28 | Alkalosis (HP:0001948) | 4.23944404 |
| 29 | Large earlobe (HP:0009748) | 4.17443270 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 4.13685976 |
| 31 | Short middle phalanx of finger (HP:0005819) | 4.08271424 |
| 32 | Vertebral clefting (HP:0008428) | 4.06841074 |
| 33 | Abnormal cartilage morphology (HP:0002763) | 3.87090086 |
| 34 | Abnormality of the 2nd finger (HP:0004100) | 3.85674715 |
| 35 | Confusion (HP:0001289) | 3.80540618 |
| 36 | Widely patent fontanelles and sutures (HP:0004492) | 3.78535091 |
| 37 | Abnormality of the phalanges of the hallux (HP:0010057) | 3.77420154 |
| 38 | Fat malabsorption (HP:0002630) | 3.76992251 |
| 39 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.76734737 |
| 40 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.75117419 |
| 41 | Vertebral hypoplasia (HP:0008417) | 3.75117419 |
| 42 | Aplasia/hypoplasia of the femur (HP:0005613) | 3.67061042 |
| 43 | Short phalanx of the thumb (HP:0009660) | 3.62220157 |
| 44 | Coronal craniosynostosis (HP:0004440) | 3.60226700 |
| 45 | Absent phalangeal crease (HP:0006109) | 3.53026305 |
| 46 | Abnormal hand bone ossification (HP:0010660) | 3.52514103 |
| 47 | Abnormal vertebral ossification (HP:0100569) | 3.51525233 |
| 48 | Abnormal ossification of hand bones (HP:0005921) | 3.51019313 |
| 49 | Hypoplastic ilia (HP:0000946) | 3.49702519 |
| 50 | Tracheal stenosis (HP:0002777) | 3.46347643 |
| 51 | Abnormality of vitamin metabolism (HP:0100508) | 3.44259056 |
| 52 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.44033267 |
| 53 | Short tibia (HP:0005736) | 3.42796307 |
| 54 | Breast hypoplasia (HP:0003187) | 3.42422533 |
| 55 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 3.42173069 |
| 56 | Abnormal tarsal ossification (HP:0008369) | 3.41912575 |
| 57 | Hip contracture (HP:0003273) | 3.41382138 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 3.34647556 |
| 59 | Congenital sensorineural hearing impairment (HP:0008527) | 3.28433133 |
| 60 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 3.26099653 |
| 61 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.23690239 |
| 62 | Abnormality of femoral epiphyses (HP:0006499) | 3.17422996 |
| 63 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 3.17422996 |
| 64 | Thin bony cortex (HP:0002753) | 3.11478395 |
| 65 | Abnormality of the femoral head (HP:0003368) | 3.10230882 |
| 66 | Abdominal distention (HP:0003270) | 3.09893866 |
| 67 | Nausea (HP:0002018) | 3.08961257 |
| 68 | Hemorrhage of the eye (HP:0011885) | 3.08617631 |
| 69 | Abnormality of chloride homeostasis (HP:0011422) | 2.99427987 |
| 70 | Short hallux (HP:0010109) | 2.99130747 |
| 71 | Proximal placement of thumb (HP:0009623) | 2.98518208 |
| 72 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.98083882 |
| 73 | Hyperglycinuria (HP:0003108) | 2.96307697 |
| 74 | Acanthocytosis (HP:0001927) | 2.96208029 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.94646154 |
| 76 | Abnormal finger flexion creases (HP:0006143) | 2.93008151 |
| 77 | Aplasia/Hypoplasia of the middle phalanges of the hand (HP:0009843) | 2.92811381 |
| 78 | Villous atrophy (HP:0011473) | 2.90583516 |
| 79 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.90583516 |
| 80 | Relative macrocephaly (HP:0004482) | 2.90422940 |
| 81 | Lumbar hyperlordosis (HP:0002938) | 2.90369561 |
| 82 | Hyperparathyroidism (HP:0000843) | 2.90136504 |
| 83 | Visceral angiomatosis (HP:0100761) | 2.89639529 |
| 84 | Hyperaldosteronism (HP:0000859) | 2.89433864 |
| 85 | Shawl scrotum (HP:0000049) | 2.89388069 |
| 86 | Wide cranial sutures (HP:0010537) | 2.89151911 |
| 87 | Proximal tubulopathy (HP:0000114) | 2.88916158 |
| 88 | Ridged nail (HP:0001807) | 2.88701264 |
| 89 | Down-sloping shoulders (HP:0200021) | 2.88145093 |
| 90 | Fragile nails (HP:0001808) | 2.87965853 |
| 91 | Eczematoid dermatitis (HP:0000976) | 2.85821172 |
| 92 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.84744577 |
| 93 | Flared iliac wings (HP:0002869) | 2.83298359 |
| 94 | Hip dysplasia (HP:0001385) | 2.81767930 |
| 95 | Glycosuria (HP:0003076) | 2.81480922 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.81480922 |
| 97 | High anterior hairline (HP:0009890) | 2.81385432 |
| 98 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73477621 |
| 99 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.71951068 |
| 100 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.71816354 |
| 101 | Ovoid vertebral bodies (HP:0003300) | 2.71587916 |
| 102 | Cone-rod dystrophy (HP:0000548) | 2.68767989 |
| 103 | Woolly hair (HP:0002224) | 2.68135643 |
| 104 | Deviation of the thumb (HP:0009603) | 2.68082672 |
| 105 | Hemangiomatosis (HP:0007461) | 2.63942857 |
| 106 | Abnormality of glycine metabolism (HP:0010895) | 2.60687388 |
| 107 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60687388 |
| 108 | Nephrolithiasis (HP:0000787) | 2.60310156 |
| 109 | Pigmentary retinal degeneration (HP:0001146) | 2.60172380 |
| 110 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.59076166 |
| 111 | Xanthomatosis (HP:0000991) | 2.57893662 |
| 112 | Hypokalemia (HP:0002900) | 2.56658409 |
| 113 | Lipid accumulation in hepatocytes (HP:0006561) | 2.55180280 |
| 114 | Hyperammonemia (HP:0001987) | 2.53460513 |
| 115 | Increased purine levels (HP:0004368) | 2.52029425 |
| 116 | Hyperuricemia (HP:0002149) | 2.52029425 |
| 117 | Broad palm (HP:0001169) | 2.48775120 |
| 118 | Hypotension (HP:0002615) | 2.47929510 |
| 119 | Hoarse voice (HP:0001609) | 2.47258018 |
| 120 | Pili torti (HP:0003777) | 2.46735032 |
| 121 | Abnormality of the middle phalanges of the hand (HP:0009833) | 2.45379120 |
| 122 | Hypophosphatemia (HP:0002148) | 2.43920970 |
| 123 | Abnormal foot bone ossification (HP:0010675) | 2.41933242 |
| 124 | Limited hip movement (HP:0008800) | 2.36775667 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36445012 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 2.36445012 |
| 127 | Polar cataract (HP:0010696) | 2.36244096 |
| 128 | Flat face (HP:0012368) | 2.35217993 |
| 129 | Midline defect of the nose (HP:0004122) | 2.31475513 |
| 130 | Coxa vara (HP:0002812) | 2.31430308 |
| 131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31364025 |
| 132 | Megaloblastic anemia (HP:0001889) | 2.31077329 |
| 133 | Potter facies (HP:0002009) | 2.31015728 |
| 134 | Facial shape deformation (HP:0011334) | 2.31015728 |
| 135 | Renal tubular acidosis (HP:0001947) | 2.29574178 |
| 136 | Short humerus (HP:0005792) | 2.27033982 |
| 137 | Focal segmental glomerulosclerosis (HP:0000097) | 2.26492457 |
| 138 | Glomerulonephritis (HP:0000099) | 2.25203240 |
| 139 | Abnormality of potassium homeostasis (HP:0011042) | 2.24377098 |
| 140 | Hyponatremia (HP:0002902) | 2.23644515 |
| 141 | Abnormal delivery (HP:0001787) | 2.20607239 |
| 142 | Pterygium (HP:0001059) | 2.19990477 |
| 143 | Steatorrhea (HP:0002570) | 2.19771641 |
| 144 | Hyperphosphatemia (HP:0002905) | 2.18983234 |
| 145 | Renal Fanconi syndrome (HP:0001994) | 2.18908356 |
| 146 | Intrahepatic cholestasis (HP:0001406) | 2.17546272 |
| 147 | Abnormality of complement system (HP:0005339) | 2.14852323 |
| 148 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14821415 |
| 149 | Short femoral neck (HP:0100864) | 2.14519470 |
| 150 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.13932604 |
| 151 | Conjugated hyperbilirubinemia (HP:0002908) | 2.13886668 |
| 152 | Cerebral palsy (HP:0100021) | 2.13358169 |
| 153 | Thickened nuchal skin fold (HP:0000474) | 2.12917127 |
| 154 | Growth hormone excess (HP:0000845) | 2.11178949 |
| 155 | Enlarged epiphyses (HP:0010580) | 2.09660874 |
| 156 | Abnormality of purine metabolism (HP:0004352) | 2.08722292 |
| 157 | Stillbirth (HP:0003826) | 2.08287407 |
| 158 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06873995 |
| 159 | Sandal gap (HP:0001852) | 2.06640191 |
| 160 | Exertional dyspnea (HP:0002875) | 2.03581124 |
| 161 | Delayed epiphyseal ossification (HP:0002663) | 2.02982106 |
| 162 | Protuberant abdomen (HP:0001538) | 2.02268613 |
| 163 | Abnormal hair laboratory examination (HP:0003328) | 2.02183206 |
| 164 | Petechiae (HP:0000967) | 2.01841382 |
| 165 | Short thorax (HP:0010306) | 2.00160030 |
| 166 | Short ribs (HP:0000773) | 1.99744970 |
| 167 | Abnormal biliary tract morphology (HP:0012440) | 1.99575577 |
| 168 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.99340252 |
| 169 | Pancreatitis (HP:0001733) | 1.99093838 |
| 170 | Nephritis (HP:0000123) | 1.98825711 |
| 171 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98391690 |
| 172 | Metabolic acidosis (HP:0001942) | 1.98011144 |
| 173 | Limited elbow extension (HP:0001377) | 1.97894274 |
| 174 | Complement deficiency (HP:0004431) | 1.97821342 |
| 175 | Increased muscle lipid content (HP:0009058) | 1.97315339 |
| 176 | Hypoplastic iliac wings (HP:0002866) | 1.97245907 |
| 177 | Biliary tract neoplasm (HP:0100574) | 1.96022454 |
| 178 | Dehydration (HP:0001944) | 1.95905179 |
| 179 | Gastrointestinal dysmotility (HP:0002579) | 1.94934192 |
| 180 | Abnormality of the costochondral junction (HP:0000919) | 1.93330985 |
| 181 | Abnormality of magnesium homeostasis (HP:0004921) | 1.91462131 |
| 182 | Abnormal urine phosphate concentration (HP:0012599) | 1.89885576 |
| 183 | Syncope (HP:0001279) | 1.88070302 |
| 184 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85559046 |
| 185 | Hyperphosphaturia (HP:0003109) | 1.84657606 |
| 186 | Multiple lipomas (HP:0001012) | 1.83006936 |
| 187 | Gingivitis (HP:0000230) | 1.82244460 |
| 188 | Symptomatic seizures (HP:0011145) | 1.81262937 |
| 189 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.78575696 |
| 190 | Adrenal overactivity (HP:0002717) | 1.76938537 |
| 191 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.75852194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 7.08974928 |
| 2 | EPHB2 | 5.31836465 |
| 3 | EPHA2 | 4.03607659 |
| 4 | MAP3K10 | 2.70125943 |
| 5 | PIK3CA | 2.25393916 |
| 6 | RIPK1 | 2.10729911 |
| 7 | TAOK3 | 14.7286352 |
| 8 | TAOK1 | 1.82520672 |
| 9 | FGFR4 | 1.76432726 |
| 10 | MST1R | 1.70985632 |
| 11 | KSR2 | 1.69153118 |
| 12 | ARAF | 1.59079231 |
| 13 | GRK6 | 1.55333856 |
| 14 | MAP2K2 | 1.52610824 |
| 15 | TYK2 | 1.47795964 |
| 16 | MAP4K1 | 1.39774376 |
| 17 | STK24 | 1.36332539 |
| 18 | MAP3K9 | 1.33282035 |
| 19 | EPHA3 | 1.30809997 |
| 20 | PRPF4B | 1.30364859 |
| 21 | EPHB1 | 1.26677687 |
| 22 | MAP3K2 | 1.20670473 |
| 23 | TBK1 | 1.07511784 |
| 24 | ICK | 1.02144304 |
| 25 | MAP3K14 | 1.02023300 |
| 26 | LMTK2 | 0.97498052 |
| 27 | MAP3K13 | 0.96749941 |
| 28 | TNIK | 0.91312702 |
| 29 | PRKG2 | 0.88828714 |
| 30 | RIPK4 | 0.85037609 |
| 31 | MAP3K11 | 0.83055758 |
| 32 | MYLK | 0.82719138 |
| 33 | FGFR3 | 0.81901722 |
| 34 | ILK | 0.80908205 |
| 35 | FRK | 0.80682022 |
| 36 | PTK6 | 0.76164013 |
| 37 | PTK2 | 0.73803130 |
| 38 | NME1 | 0.69501736 |
| 39 | MAP2K1 | 0.68711595 |
| 40 | MAP3K12 | 0.67911257 |
| 41 | TRIB3 | 0.64292736 |
| 42 | NLK | 0.61563178 |
| 43 | MST4 | 0.61405539 |
| 44 | SMG1 | 0.60997407 |
| 45 | DYRK1B | 0.59839406 |
| 46 | FER | 0.59368231 |
| 47 | PDPK1 | 0.55038180 |
| 48 | PTK2B | 0.53236138 |
| 49 | CAMK2D | 0.50782685 |
| 50 | CDK19 | 0.50568610 |
| 51 | IKBKE | 0.47438034 |
| 52 | ZAP70 | 0.45564363 |
| 53 | ITK | 0.45186719 |
| 54 | PDK1 | 0.41309221 |
| 55 | MOS | 0.41253326 |
| 56 | PRKCZ | 0.40562423 |
| 57 | IRAK1 | 0.40114758 |
| 58 | JAK2 | 0.39551458 |
| 59 | BRAF | 0.38996604 |
| 60 | STK11 | 0.38961939 |
| 61 | MAP3K8 | 0.38904040 |
| 62 | BMX | 0.38136032 |
| 63 | MATK | 0.38010405 |
| 64 | FYN | 0.37463040 |
| 65 | PDGFRA | 0.37137654 |
| 66 | MAP3K1 | 0.37120505 |
| 67 | MET | 0.36945678 |
| 68 | PRKD2 | 0.36773132 |
| 69 | YES1 | 0.36540130 |
| 70 | AKT3 | 0.36487428 |
| 71 | JAK1 | 0.34816122 |
| 72 | ERBB2 | 0.34504772 |
| 73 | TESK1 | 0.31965716 |
| 74 | PRKCQ | 0.31608476 |
| 75 | CAMK2B | 0.30957079 |
| 76 | MAPKAPK2 | 0.30750931 |
| 77 | LYN | 0.29682439 |
| 78 | RPS6KA2 | 0.29558479 |
| 79 | AURKB | 0.29462303 |
| 80 | DYRK2 | 0.28755747 |
| 81 | MAP3K3 | 0.28604574 |
| 82 | PKN1 | 0.28395799 |
| 83 | SRC | 0.28369154 |
| 84 | PRKCD | 0.27820685 |
| 85 | MAPK11 | 0.27492012 |
| 86 | CSF1R | 0.27136517 |
| 87 | CAMK2G | 0.26059820 |
| 88 | DMPK | 0.25957465 |
| 89 | PIM2 | 0.25499279 |
| 90 | PAK1 | 0.24737857 |
| 91 | CSK | 0.24360492 |
| 92 | PIM1 | 0.23723273 |
| 93 | MAPKAPK3 | 0.22460482 |
| 94 | LRRK2 | 0.21928485 |
| 95 | PIK3CG | 0.21805686 |
| 96 | MELK | 0.21798886 |
| 97 | PRKCA | 0.21770999 |
| 98 | CDK6 | 0.21549427 |
| 99 | TTK | 0.21375143 |
| 100 | RPS6KB2 | 0.21074356 |
| 101 | IRAK4 | 0.21012632 |
| 102 | JAK3 | 0.20015273 |
| 103 | SYK | 0.19930277 |
| 104 | DAPK3 | 0.19439053 |
| 105 | DDR2 | 0.19287888 |
| 106 | PRKCI | 0.18723646 |
| 107 | PDK2 | 0.18634401 |
| 108 | CSNK1A1 | 0.18567527 |
| 109 | RAF1 | 0.18520702 |
| 110 | BMPR2 | 0.16243220 |
| 111 | KIT | 0.15622961 |
| 112 | ABL2 | 0.15411918 |
| 113 | FGFR1 | 0.14429847 |
| 114 | ZAK | 0.13185650 |
| 115 | TTN | 0.12095342 |
| 116 | TESK2 | 0.11616704 |
| 117 | SGK494 | 0.11207703 |
| 118 | SGK223 | 0.11207703 |
| 119 | CAMK2A | 0.09910442 |
| 120 | CDC42BPA | 0.09719914 |
| 121 | PAK4 | 0.09559341 |
| 122 | PRKD1 | 0.08060850 |
| 123 | TEC | 0.07878839 |
| 124 | BTK | 0.06696542 |
| 125 | OXSR1 | 0.05963181 |
| 126 | IGF1R | 0.05575053 |
| 127 | PRKAA2 | 0.05511666 |
| 128 | PRKCB | 0.05363014 |
| 129 | WNK4 | 0.05314790 |
| 130 | PRKACG | 0.04808424 |
| 131 | ERN1 | 0.03834045 |
| 132 | CDK15 | 0.03815521 |
| 133 | MAP3K7 | 0.03660850 |
| 134 | MAP2K6 | 0.03643784 |
| 135 | EPHA4 | 0.02444395 |
| 136 | STK39 | 0.02420874 |
| 137 | CDK18 | 0.01618726 |
| 138 | CLK1 | 0.01478243 |
| 139 | PLK1 | 0.01194355 |
| 140 | RET | 0.01110769 |
| 141 | RPS6KA1 | 0.00815681 |
| 142 | KSR1 | 0.00343288 |
| 143 | FGR | 0.00244701 |
| 144 | ADRBK1 | -0.0038500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 7.16982210 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.03951871 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.49127172 |
| 4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.37456599 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.94253997 |
| 6 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.89575538 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.71239955 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.53859198 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.36931126 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27670650 |
| 11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.18557391 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.14881828 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.90767737 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.81248765 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.80218201 |
| 16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79244466 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75235684 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71029025 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.67698301 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.66150978 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53088358 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.50776407 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.49099986 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47768148 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39391103 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38551423 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.37660310 |
| 28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.34672487 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33038947 |
| 30 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31016692 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26928037 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.19922525 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19012349 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15990830 |
| 35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14736194 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14730193 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13581133 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.13158108 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06223067 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04698135 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04152648 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03771791 |
| 43 | Allograft rejection_Homo sapiens_hsa05330 | 1.03580326 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03527208 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01788247 |
| 46 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01646306 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.01040920 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.00848694 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96750357 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.93660342 |
| 51 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92479894 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91955808 |
| 53 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86179703 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83436485 |
| 55 | Tight junction_Homo sapiens_hsa04530 | 0.79881402 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79760489 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79491774 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78596008 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78502146 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.78200338 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77442377 |
| 62 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74411172 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.73294818 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71235731 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70149716 |
| 66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.69328646 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67464829 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67381584 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.65620057 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62925464 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61887406 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61339385 |
| 73 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58469582 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57077667 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57042302 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.56122506 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.54959088 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54838856 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54747820 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54589498 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52963758 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51927810 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49891609 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49789558 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48512624 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.47058297 |
| 87 | Axon guidance_Homo sapiens_hsa04360 | 0.46934945 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45709739 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45047853 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42025104 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41480945 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40955489 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.40575144 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40048325 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.39688958 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38740425 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.38596239 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37733791 |
| 99 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37659705 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37115664 |
| 101 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36711437 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36689547 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36466886 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.36201198 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.34437357 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.33703810 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31876580 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31045181 |
| 109 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30808672 |
| 110 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29900856 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.29781609 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29637831 |
| 113 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28991143 |
| 114 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27133688 |
| 115 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.26173144 |
| 116 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26162875 |
| 117 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.26126746 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25735115 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25694530 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24864284 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24321103 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23503678 |
| 123 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21840347 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21625470 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.21615004 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20761780 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.20303868 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19158089 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.17633932 |
| 130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.17579338 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.17376695 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16344138 |
| 133 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15240751 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.14136317 |
| 135 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.11844465 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.09638404 |
| 137 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.08924625 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08721294 |
| 139 | Tuberculosis_Homo sapiens_hsa05152 | 0.07397899 |
| 140 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.05796976 |

